Why the study?
Routine perioperative high-fraction oxygen is recommended as standard of care, but whether it provides true benefit or potential harm has been challenged.
Does perioperative high (80%) fraction of inspired oxygen reduce surgical site infection and mortality in adult surgical patients compared to 30% FiO2?
Does perioperative high (80%) fraction of inspired oxygen reduce surgical site infection and mortality in adult surgical patients compared to 30% FiO2?
Perioperative high fraction of inspired oxygen (80%) does not significantly reduce surgical site infections or mortality compared to 30% oxygen in adult surgical patients.
No reduction in SSI or mortality with 80% vs 30% FiO2; challenges WHO-endorsed routine high perioperative oxygen use.
Objective To determine the effects of perioperative high (80%) versus low (30%) fraction of inspired oxygen (FiO 2 ) on surgical site infection (SSI) and mortality in adult surgical patients. Background The routine use of high fraction perioperative oxygen in patients is “standard of care” and recommended by the World Health Organisation; however, whether there is truly any benefit to this therapy has been challenged by some authors. Questions have also been raised about the possibility of harm from oxygen therapy. Method Randomised control trials comparing high‐to‐low FiO 2 were located by searching MEDLINE , Embase , CENTRAL and Web of Science. The primary outcomes were SSI up to 15 days and up to any time point postoperatively and mortality up to 30 days. The data were analysed using random effects meta‐analysis. Results Twelve studies involving 10,212 participants were included. At 15 days postoperatively, and at the longest point of post‐operative follow‐up, there was no statistically significant reduction in the risk of SSI when comparing patients who received a perioperative FiO 2 of 30% to those with an FiO 2 of 80% (RR 1.41, 95% CI 1.00–2.01, p 0.05 and RR 1.23, 95% CI 1.00–1.51, p 0.05). There was no statistically significant difference in mortality between the 30% FiO 2 and the 80% FiO 2 groups (RR 1.12, 95% CI 0.56–2.22, p 0.76). Conclusion This meta‐analysis showed no statistically significant difference in post‐operative SSI or mortality when comparing patients receiving an FiO 2 of 80% to those receiving an FiO 2 of 30%.
No takes yet. Share an insight, caveat, or question.
Smith et al. (2019) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: